Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated May 15, 2013 titled "Glenmark Generics receives final ANDA approvals for Zolmitriptan Tablest, 2.5 and 5 mg and Zolmitriptan Orally Disintegrating Tablest, 2.5 and 5 mg."Source : BSE
Read all announcements in Glenmark
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!